Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6–59 months of age: A phase 3, randomized, noninferiority study by Statler, Victoria A., Albano, Frank R., Airey, Jolanta, Sawlwin, Daphne C., Graves Jones, Alison, Matassa, Vince, Heijnen, Esther, Edelman, Jonathan, Marshall, Gary S.

Get full text

Reply to Letter to the Editor by Hu, Wilson, Sawlwin, Daphne C

Get full text

Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A pha... by Treanor, John T, Albano, Frank R, Sawlwin, Daphne C, Graves Jones, Alison, Airey, Jolanta, Formica, Neil, Matassa, Vince, Leong, Jane

Get full text

Modification of the vaccine manufacturing process improves the pyrogenicity profile of inactivated influenza vaccines in young children by Sawlwin, Daphne C, Graves Jones, Alison, Albano, Frank R

Get full text

Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A p... by Airey, Jolanta, Albano, Frank R, Sawlwin, Daphne C, Jones, Alison Graves, Formica, Neil, Matassa, Vince, Leong, Jane

Get full text

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children by Nolan, Terry, Richmond, Peter C, Formica, Neil T, Höschler, Katja, Skeljo, Maryanne V, Stoney, Tanya, McVernon, Jodie, Hartel, Gunter, Sawlwin, Daphne C, Bennet, Jillian, Ryan, David, Basser, Russell L, Zambon, Maria C

Get full text

Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children by Brady, Rebecca C, Hu, Wilson, Houchin, Vonda G, Eder, Frank S, Jackson, Kenneth C, Hartel, Gunter F, Sawlwin, Daphne C, Albano, Frank R, Greenberg, Michael

Get full text